Category: Clinical Research 101

  • What Happens at Your First Clinical Research Study Visit

    What Happens at Your First Clinical Research Study Visit

    Thinking about joining a clinical research study but not sure what to expect? Knowing what happens at the first visit can make the experience feel much less intimidating. Here is a simple walk-through of a typical first visit at a research site like ours. Every study is different, so your study team will explain the details for your study.

    Before your visit

    Most people first talk with a member of the study team by phone. They will ask a few general questions to see if a study might be a good fit, explain the basics and schedule your first visit, often called a screening visit. They will tell you if you need to do anything special beforehand, such as not eating for a few hours.

    What to bring

    • A photo ID
    • A list of all your medicines, including vitamins and over-the-counter products, or bring the bottles
    • Names of your doctors and any recent medical records, if you have them
    • Your glasses, if you need them for reading
    • A list of questions you want to ask

    Plan for the visit to take a few hours. Ask when you schedule how long to expect.

    Step 1: Welcome and check-in

    A member of our team will greet you, check you in and answer any first questions. You are welcome to bring a family member or friend for support.

    Step 2: Informed consent

    Before anything else happens, a study team member will go through the informed consent form with you. This document explains:

    • Why the study is being done
    • What will happen at each visit and how long the study lasts
    • Possible risks and possible benefits
    • Other options you have if you do not join
    • How your information will be kept private
    • Whether you will receive compensation for your time and travel
    • Who to contact with questions

    Take your time. Ask as many questions as you like, and you can take the form home to think it over or talk with your family or doctor. You only sign if and when you are ready. Signing does not lock you in: you can leave a study at any time, for any reason.

    Step 3: Health checks

    After you sign, the team will check whether you meet the study’s requirements. Depending on the study, this may include:

    • Questions about your health history and medicines
    • Height, weight, blood pressure and heart rate
    • A physical exam
    • Blood or urine tests
    • An ECG (a painless test of your heart’s rhythm)
    • Other tests specific to the study, such as a breathing test

    Every test should be explained to you before it happens.

    Step 4: Next steps

    Some test results take a few days. The study team will let you know whether you qualify. If you do, they will explain the visit schedule and what happens next. If you do not qualify, that is common and not a reflection on you. Studies have very specific requirements, and another study may be a better fit later.

    Questions you may want to ask

    • What is the purpose of this study?
    • How many visits are there, and how long is each one?
    • What tests or procedures will I have?
    • Will I need to stop or change any of my current medicines?
    • Could I receive a placebo?
    • Will it cost me anything? Will I be compensated for my time and travel?
    • What happens if I get hurt or have a side effect?
    • Who do I call if I have a question after hours?

    You are in control

    Joining a study is always your choice. A good research team wants you to feel informed and comfortable at every step, and will never pressure you to sign up or stay in.

    Interested in clinical research?

    Pivotal Research Solutions is a clinical research site in Lithonia, GA. If you would like to hear about research studies that may be a fit for you, join our Study Interest List. Joining is free, takes about two minutes and does not sign you up for any study. Questions? Call 678-825-2887 or email contact@pivotalrs.com.

    Sources

    This article is for general education only and is not medical advice. Talk with your own doctor or health care provider about what is right for you.

  • 7 Common Myths About Clinical Research, Answered

    7 Common Myths About Clinical Research, Answered

    Clinical research is how new medicines, vaccines and medical devices are tested before doctors can use them. Yet many people hold back from taking part because of things they have heard. Here are seven common myths, and the facts behind them.

    Myth 1: “Research volunteers are just guinea pigs.”

    Fact: Volunteers are partners in research, and they are protected by strict rules. Before a study can begin, it must be reviewed and approved by an Institutional Review Board (IRB), an independent group whose job is to protect the rights and safety of participants. Many studies are also overseen by the U.S. Food and Drug Administration (FDA). Study teams watch participants closely throughout the study.

    Myth 2: “If I join, I’ll just get a sugar pill.”

    Fact: Not every study uses a placebo (an inactive look-alike). When a study does, you will be told before you agree to join, and you will learn your chances of receiving it. In many studies, everyone gets either the study treatment or the standard treatment, or the placebo is added on top of usual care.

    Myth 3: “Once I sign up, I can’t change my mind.”

    Fact: Taking part is always voluntary. You can leave a study at any time, for any reason, without losing access to your regular medical care. You do not have to explain why.

    Myth 4: “Clinical trials are only for people who have run out of options.”

    Fact: Studies need many kinds of people. Some studies look for people with a specific condition at any stage, and some look for healthy volunteers. Research also tests ways to prevent disease, detect it earlier or improve quality of life.

    Myth 5: “It will cost me a lot of money.”

    Fact: In many studies, the study medicine and study-related visits and tests are provided at no cost to you, and some studies offer compensation for your time and travel. Costs and compensation are different for every study, and they must be explained in the informed consent form before you decide.

    Myth 6: “My personal information will be shared.”

    Fact: Research teams are required to protect your privacy. Your records are usually labeled with a code instead of your name, and the consent form explains who can see your information and why. Ask the study team any questions you have about privacy.

    Myth 7: “Research isn’t for people like me.”

    Fact: Research needs people of every age, race, ethnicity and background. Medicines can work differently in different people, so studies are stronger when volunteers reflect the communities that will use the treatments.

    The bottom line

    Asking questions is always welcome. A good study team will take the time to explain everything and will never pressure you to join or stay in a study.

    Interested in clinical research?

    Pivotal Research Solutions is a clinical research site in Lithonia, GA. If you would like to hear about research studies that may be a fit for you, join our Study Interest List. Joining is free, takes about two minutes and does not sign you up for any study. Questions? Call 678-825-2887 or email contact@pivotalrs.com.

    Sources

    This article is for general education only and is not medical advice. Talk with your own doctor or health care provider about what is right for you.

  • Why Diverse Participation in Clinical Trials Matters

    Why Diverse Participation in Clinical Trials Matters

    When you take a medicine, you want to know it works and is safe for someone like you. That is exactly why clinical trials need volunteers from every background.

    Why it matters

    People can respond differently to the same medicine. Age, sex, genetics, other health conditions, diet and environment can all play a role. If a study includes only one group of people, researchers may miss how a treatment works for everyone else.

    Some health conditions also affect certain communities more often or more severely. For example, high blood pressure, type 2 diabetes and kidney disease are more common among Black Americans. Including people from these communities in research helps make sure new treatments are tested in the people most likely to use them.

    The gap is real

    Black Americans make up about 14% of the U.S. population, according to the U.S. Census Bureau. Yet among everyone who took part in the trials behind the new drugs the FDA approved in 2020, here and overseas, only about 8% were Black or African American, according to the agency’s 2020 Drug Trials Snapshots report. The FDA has stopped publishing a single combined figure since then, so 2020 is the most recent year with one number to point to. Other groups, including Hispanic and Latino communities, older adults and people living in rural areas, are also often underrepresented.

    History and trust

    Many people in the Black community have good reason to be cautious about research. From 1932 to 1972, the U.S. Public Health Service ran the Untreated Syphilis Study at Tuskegee, in which Black men were not told the truth about their condition and were denied effective treatment. It is a painful part of history that should never be forgotten.

    That study led directly to stronger protections for everyone who takes part in research today, including:

    • Informed consent: you must be told the purpose, risks and possible benefits of a study, in plain language, before you agree.
    • Independent review: an Institutional Review Board must approve every study and monitor it to protect participants.
    • The right to say no or to leave at any time, without losing your regular medical care.

    What you can do

    You do not have to join a study to make a difference. You can learn about research, ask questions, and share what you learn with family and friends. If you are interested in taking part, look for a research site that takes time to answer your questions and treats you with respect.

    Our commitment

    At Pivotal Research Solutions, our mission is to bridge the gap between research and the community we serve in Lithonia and the greater Atlanta area. We believe everyone deserves the chance to learn about research and decide for themselves, with honest information and no pressure.

    Interested in clinical research?

    Pivotal Research Solutions is a clinical research site in Lithonia, GA. If you would like to hear about research studies that may be a fit for you, join our Study Interest List. Joining is free, takes about two minutes and does not sign you up for any study. Questions? Call 678-825-2887 or email contact@pivotalrs.com.

    Sources

    This article is for general education only and is not medical advice. Talk with your own doctor or health care provider about what is right for you.

  • Your Rights as a Clinical Research Participant

    Your Rights as a Clinical Research Participant

    If you are thinking about joining a clinical research study, it helps to know that you have important rights. These rights are protected by federal rules and by the independent review boards that oversee research. Here is what every research volunteer should know.

    1. The right to informed consent

    Before you join, the study team must explain the study to you in language you understand. This includes:

    • Why the study is being done
    • What will happen and how long it will last
    • Possible risks and discomforts
    • Possible benefits, if any
    • Other options available to you
    • How your information will be kept private
    • Any costs or compensation
    • Who to contact with questions or concerns

    You will get this information in writing, in an informed consent form. Informed consent is not just a signature. It is an ongoing conversation that continues for as long as you are in the study.

    2. The right to take your time and ask questions

    You never have to decide on the spot. You can take the consent form home, talk it over with family or your own doctor, and come back with questions. Ask as many questions as you like, at any time.

    3. The right to say no

    Joining a study is always voluntary. Saying no will not affect the regular medical care you receive.

    4. The right to leave at any time

    You can stop taking part in a study at any time, for any reason, even after you have signed the consent form. You do not have to give a reason. The study team may ask to do a final check-up for your safety, but you are free to decline.

    5. The right to privacy

    Your personal and health information must be protected. The consent form explains what information will be collected, who can see it and how it will be used. Research records are usually labeled with a code number instead of your name.

    6. The right to new information

    If the study team learns something new that could affect your willingness to stay in the study, such as a newly found risk, they must tell you.

    7. The right to know who to contact

    You should receive contact information for the study team and for the Institutional Review Board (IRB) that oversees the study. If you have a concern about your rights or how you are being treated, you can contact the IRB directly.

    8. The right to a copy

    You should receive a copy of your signed consent form to keep.

    Questions to ask before you join

    • What is the main purpose of this study?
    • What will I be asked to do, and how much time will it take?
    • What are the possible risks and benefits?
    • Will I have to pay for anything? Will I be compensated?
    • What happens if I am harmed during the study?
    • Who will see my information?
    • Can I talk to my regular doctor about this?

    Our promise

    At Pivotal Research Solutions in Lithonia, GA, we take time to explain every study and answer every question. You are always in control of your decision.

    Interested in clinical research?

    Pivotal Research Solutions is a clinical research site in Lithonia, GA. If you would like to hear about research studies that may be a fit for you, join our Study Interest List. Joining is free, takes about two minutes and does not sign you up for any study. Questions? Call 678-825-2887 or email contact@pivotalrs.com.

    Sources

    This article is for general education only and is not medical advice. Talk with your own doctor or health care provider about what is right for you.

  • The Phases of Clinical Trials, Explained Simply

    The Phases of Clinical Trials, Explained Simply

    Before a new medicine can be prescribed by doctors, it goes through years of careful testing. Clinical trials happen in steps called phases. Each phase answers different questions, and a medicine must pass each step before moving to the next. Here is a simple guide, based on information from the U.S. Food and Drug Administration (FDA).

    Before people: lab and animal studies

    Researchers first study a possible medicine in the lab. If early results look promising and reasonably safe, the company or research team asks the FDA for permission to begin testing in people.

    Phase 1: Is it safe, and what dose?

    • Who takes part: about 20 to 100 people, either healthy volunteers or people with the condition
    • How long: several months
    • Main goal: learn about safety, side effects and the right dose

    According to the FDA, about 70% of drugs move on to the next phase.

    Phase 2: Does it work?

    • Who takes part: up to several hundred people with the condition
    • How long: several months to 2 years
    • Main goal: learn whether the medicine works and keep checking for side effects

    About 33% of drugs move on to Phase 3.

    Phase 3: How does it compare?

    • Who takes part: about 300 to 3,000 people with the condition
    • How long: 1 to 4 years
    • Main goal: confirm whether the medicine works, watch for less common side effects and often compare it with current treatments

    About 25% to 30% of drugs move on. After Phase 3, the company may ask the FDA to approve the medicine. FDA experts carefully review all the data before deciding.

    Phase 4: After approval

    • Who takes part: several thousand people with the condition
    • Main goal: keep monitoring safety and effectiveness once the medicine is available to the public

    Phase 4 studies can reveal rare side effects or long-term effects that only show up when many more people use a medicine.

    Why so many steps?

    Each phase builds on what was learned before, and only medicines that show promise move forward. This careful process protects volunteers and helps make sure the medicines your doctor prescribes have been tested thoroughly.

    How volunteers are protected in every phase

    • An independent review board must approve every study before it starts.
    • Every volunteer goes through informed consent and can ask questions at any time.
    • Taking part is always voluntary, and you can leave a study whenever you choose.
    • Study teams closely monitor participants’ health throughout.

    Where research sites fit in

    Research sites like Pivotal Research Solutions in Lithonia, GA, work with study sponsors to carry out trials in our community, so local volunteers have the chance to take part in research close to home.

    Interested in clinical research?

    Pivotal Research Solutions is a clinical research site in Lithonia, GA. If you would like to hear about research studies that may be a fit for you, join our Study Interest List. Joining is free, takes about two minutes and does not sign you up for any study. Questions? Call 678-825-2887 or email contact@pivotalrs.com.

    Sources

    This article is for general education only and is not medical advice. Talk with your own doctor or health care provider about what is right for you.